PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bio-Modeling Systems

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BMSystems & The Max Planck Institute of Psychiatry in Munich Co-publish in Pharmaco-Psychiatry - BMSystems & The Max Planck Institute of Psychiatry in Munich co-publish in Pharmaco-Psychiatry a new analytical paradigm, for the identification of “targeted pertinent biomarkers” in psychiatric disorders
BMSystems & The Max Planck Institute of Psychiatry in Munich Co-publish in Pharmaco-Psychiatry

 

NewswireToday - /newswire/ - Paris, Ile-de-France, France, 2011/03/09 - BMSystems & The Max Planck Institute of Psychiatry in Munich co-publish in Pharmaco-Psychiatry a new analytical paradigm, for the identification of “targeted pertinent biomarkers” in psychiatric disorders.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. François Iris, BMSystems, and Prof. Chris W. Turck, the Max Planck Institute of Psychiatry, co-publish a reference article “Proteome-Based Pathway Modelling of Psychiatric Disorders” that describes a new analytical paradigm to definitively move research from “plethoric statistical biomarkers” to “targeted pertinent biomarkers” identification, exploiting a very strict synergic combination of Dynamic Quantitative Proteomic outputs with BMSystems’ unique CADI™ heuristic modeling.

We invite you to visit our new website and to download the publication

Beyond this publication, this new analytical paradigm will be presented at the 19th European Congress of Psychiatry: Vienna, Austria, 12-15 March 2011, organised by the European Psychiatric Association (EPA), the largest international association of psychiatrists in Europe. Dr. François IRIS is invited to present: "Methodology of Mapping in Integrative Molecular Biology associated to psychiatric and cognitive disorders".

This very productive research collaboration, started in 2008 with the publication of BioMarkers for Psychiatric Disorders, represent for both parties a strong potential for medical innovations and value creation.

About BMSYSTEMS
Being the first, and to date, the only company that succeeded to create validated in-silico heuristic models of complex human pathologies and physiological processes, we offer to pharma companies the possibility to generate new & pertinent hypotheses, stop in time existing programs and launch lower risks, novel therapeutics programs without being obliged to change their existing R&D discovery processes.

Created in 2004, and profitable since 2006, we designed a unique heuristic systems biology business offer to provide all our partners and clients with a simplified results-oriented research paradigm that alleviates global R&D/business issues.
Because we do not sell our technologies, but deliver their outputs in open formats, our clients are not dependent upon external proprietary technologies to maintain and update these new & pertinent hypotheses.

Because clients' proprietary data protection is critical, we do not use their proprietary data to generate the first version of a CADI model, and we limit data transfers to experimentations results only during the CADI model’s validation phase.
If you are interested to learn more about our recent achievements and possible collaborations in the fields of neurodegenerative diseases, psychiatric and cognitive disorders, infectious diseases and cancer we shall be happy to meet your company’s representatives at Bio in Washington, June 27-30, 2011.

Manuel Gea, Co-founder & CEO
BIO-MODELING SYSTEMS Predictive Integrative Biology

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bio-Modeling Systems

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BMSystems & The Max Planck Institute of Psychiatry in Munich Co-publish in Pharmaco-Psychiatry

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Manuel Gea - BMSystems.net 
+33(0)6 83 06 12 72 manuel.gea[.]bmsystems.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Modeling Systems securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Modeling Systems / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)